Founders Shantanu Jain and Sania Arora Jain of Biome Life Sciences India Pvt. Ltd. have formally withdrawn their petition filed in the Delhi High Court against their parent company, Fabindia Ltd. The legal move signifies a shift in the dispute resolution process, as the matter will now proceed before a newly constituted three-member arbitral tribunal.
The core of the disagreement involved the valuation of the founders' stake in Biome Life Sciences, a subsidiary housing Fabindia's personal care brand, FabEssentials. The founders had sought a valuation of ₹196.16 crore, citing a shareholder agreement (SHA) that included an 'exit clause' or 'put option'. This clause reportedly allowed them to sell their shares based on a pre-determined formula: either 10 times the previous financial year's sales or 40 times the Ebitda (Earnings Before Interest, Taxes, Depreciation, and Amortization), whichever was higher.
The founders alleged that Fabindia breached the SHA by failing to honor this put option within the stipulated 15 days and by raising objections not originally part of the contract. They characterized Fabindia's actions as 'arbitrary and mala fide,' intended to stall compliance and 'arm-twist' them.
Following the alleged breach, the founders initiated arbitration proceedings on September 20, 2025. Fabindia appointed its arbitrator the next day, agreeing to the arbitration reference. The Delhi High Court had previously directed Fabindia to respond to the founders' plea.
Biome Life Sciences, incorporated in May 2020 and majority-owned by Fabindia, has shown growth. In FY25, it reported a 28% year-on-year revenue increase to ₹21.6 crore and a net profit growth of over 1.5x to ₹7.1 crore. As of FY25, the founders held a 49.99% stake.
Impact
This withdrawal means the legal battle in court is paused, with the dispute now moving to arbitration. The arbitral tribunal will examine the shareholder agreement and decide on the valuation of the founders' shares, potentially leading to a significant financial settlement for them. For Fabindia, this shifts the resolution process out of public court. The broader Indian stock market impact is likely limited, as it involves a private company's internal dispute. However, it highlights the importance of clear contractual terms and dispute resolution mechanisms in founder exits and private equity deals within India.
Rating: 7/10
Difficult Terms Explained:
- Petition: A formal written request submitted to a court asking for a specific ruling or order.
- Arbitral Tribunal: A panel of one or more individuals appointed to hear and decide a dispute outside of traditional court proceedings.
- Exit Clause: A provision within a contract that outlines the conditions and terms under which a party can withdraw from the agreement or sell their stake.
- Share Valuation: The process of determining the economic worth of a company's shares.
- Put Option: A financial contract that gives the owner the right, but not the obligation, to sell an asset (like shares) at a specified price within a certain period.
- Shareholder Agreement (SHA): A contract between the shareholders of a company that governs their rights, responsibilities, and the management of the company.
- Ebitda (Earnings Before Interest, Taxes, Depreciation, and Amortization): A financial metric used to measure a company's operating performance. It indicates profitability before accounting for interest expenses, taxes, depreciation, and amortization.
- Mala fide: Acting in bad faith; with malicious intent or dishonesty.